ArticleAlimentary pharmacology & therapeutics2024

Metabolic dysfunction-associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study.

Yewan Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.